From the massive amounts of useful customer-generated data to the exponential growth in computing power, to cheaper, faster data storage and the development of deep neural networks, artificial intelligence (AI) is getting easier and easier to implement. But how does AI rank in the minds of pharmaceutical executives?
To learn more, check out our thoughts in this article we produced for our friends at PharmaPhorum, and stay tuned for more insights on this increasingly important technology.
Why AI Equity Is the Next Step for Transformational Pharma
Artificial intelligence is here to stay, and it has the potential to improve health outcomes when done right. But is the data informing your AI biased? How can you know, and what can you do about it? Intouch’s VP of innovation, Abid Rahman, shares insights and advice.
Intouch & Athenex Oncology Talk AI at Frontiers Health Global Hybrid Conference
What’s the best approach for investments in AI-based implementations? At this year’s Frontiers Health conference, Intouch experts will discuss the ‘what’ and ‘how’; we’ll also hear a case study on creating an augmented-reality tool to help oncology HCPs empathize with patients undergoing chemotherapy, developed together with Athenex Oncology.